 |
 |
|
|
|
| Enfuvirtide Acetate |
 |
| C204H301N51O64 |
 |
| 159519-65-0 |
 |
| It is applicable to the treat chronic human immunodeficiency virus infection of adults and children over 6 years old. |
 |
Parameters of Product:
1 .Appearance :White powder
2 .Water Content(Karl Fischer) :ЎВ5.0%
3 .Acetate Content(by HPLC) :ЎВ10.0%
4 .Amino Acid Composition :Ўѕ15% of theoretical
5 .Purity (by HPLC) :ЎГ95.0%
6 .Single Impurity(by HPLC) :ЎВ2.0%
7 .Peptide Content(by %N) :ЎГ80%
8 .Assay(By Anhydrous, Acetic Acid-free ) :95.0~105.0%
9 .Bacterial Endotoxins :ЎВ5EU/mg
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
